THE BUSINESS OF BIOTECH
Circular RNA with Orna Therapeutics' Tom Barnes, Ph.D. and Advancing RNA's Anna Rose Welch
As if Orna Therapeutics' CEO, Thomas Barnes, isn't enough to draw you in to the Business of Biotech, we teamed up with Advancing RNA Editorial & Community Director Anna Rose Welch to co-host this week's episode. Together, Anna Rose and I press Dr. Barnes on his transition from academia to biotech, the therapeutic proposition of circular, or "O", RNA and why it holds great potential to best linear RNA constructs, the novel, platform- and partnership-based approaches Orna is taking to address B-cell lymphomas and Duchenne Muscular Dystrophy, viral vector and lipid nanoparticle complexity, and a whole lot more.
ABOUT THE BUSINESS OF BIOTECH
Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.
FEATURED GUESTS
Thomas Barnes
Rahul Kakkar
Bobby Reddy
Jason Gardner
Karen Harris
Michael Nally
Gavin Samuels
Robert Williamson
Brian Finrow
Jack Hoppin
MEET THE HOST
Hosted by Bioprocess Online Chief Editor Matt Pillar, The Business of Biotech brings you weekly intelligence and insight, from leading voices in the biotech industry.
Interested in joining us on air ? Contact us
RECENT EPISODES
FINANCE & CAPITAL MARKETS
IL-2 Program Profits With Bonum's Drs. John Mulligan And Neela Patel
DISCOVERY
REGULATORY
MANUFACTURING
mAb Manufacturing with Rezolute Bio's Nevan Charles Elam, JD
Episode 6: Building An All-Star Biotech Team With Vivek Ramaswamy
Peptides & Proteins: Resetting The Immune System With Revolo CEO Jonathan Rigby
Orchard Tx's Bobby Gaspar On Manufacturing Hematopoietic Stem Cells
